El. Streck et al., Effect of phenylalanine and p-chlorophenylalanine on Na+,K+-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats, METAB BRAIN, 15(2), 2000, pp. 105-114
Na+,K+-ATPase activity was measured In synaptic plasma membrane from cerebr
al cortex of Wistar rats subjected to experimental phenylketonuria, i.e., c
hemical hyperphenylalaninemia induced by subcutaneous administration of 5.2
mu mol phenylalanine / g body weight (twice a day) plus 0.9 mu mol p-chlor
ophenylalanine / g body weight (once a day). The treatment was performed fr
om the 6(th) to the 14(th) postpartum day and rats were killed 12 h after t
he last injection. Synaptic plasma membrane from cerebral cortex was prepar
ed by a discontinuous density sucrose gradient for Na+,K+-ATPase activity d
etermination. The results showed that the enzyme activity was decreased by
30% in animals subjected to experimental phenylketonuria when compared to c
ontrol. The in vitro effects of the drugs on Na+,K+-ATPase activity were al
so investigated. Phenylalanine and p-chlorophenylalanine inhibited the enzy
me activity and this inhibition was reversed by alanine. In addition, compe
tition between phenylalanine and p-chlorophenylalanine for binding to the e
nzyme was observed, suggesting a common binding site for these substances.
Our results suggest that reduction of Na+,K+-ATPase activity may be one of
the mechanisms related to the brain dysfunction observed in human PKU.